Sliding-strip microfluidic device enables ELISA on paper

DSpace/Manakin Repository

Sliding-strip microfluidic device enables ELISA on paper

Citable link to this page


Title: Sliding-strip microfluidic device enables ELISA on paper
Author: Verma, Mohit S.; Tsaloglou, Maria-Nefeli; Sisley, Tyler; Christodouleas, Dionysios; Chen, Austin; Milette, Jonathan; Whitesides, George McClelland

Note: Order does not necessarily reflect citation order of authors.

Citation: Verma, Mohit S., Maria-Nefeli Tsaloglou, Tyler Sisley, Dionysios Christodouleas, Austin Chen, Jonathan Milette, and George M. Whitesides. 2018. “Sliding-Strip Microfluidic Device Enables ELISA on Paper.” Biosensors and Bioelectronics 99 (January): 77–84. doi:10.1016/j.bios.2017.07.034.
Full Text & Related Files:
Abstract: This article describes a 3D microfluidic paper-based analytical device that can be used to conduct an enzyme-linked immunosorbent assay (ELISA). The device comprises two parts: a sliding strip (which contains the active sensing area) and a structure surrounding the sliding strip (which holds stored reagents—buffers, antibodies, and enzymatic substrate—and distributes fluid). Running an ELISA involves adding sample (e.g. blood) and water, moving the sliding strip at scheduled times, and analyzing the resulting color in the sensing area visually or using a flatbed scanner. We demonstrate that this device can be used to detect C-reactive protein (CRP)—a biomarker for neonatal sepsis, pelvic inflammatory disease, and inflammatory bowel diseases—at a concentration range of 1-100 ng/mL in 1000-fold diluted blood (1-100 µg/mL in undiluted blood). The accuracy of the device (as characterized by the area under the receiver operator characteristics curve) is 89% and 83% for cut-offs of 10 ng/mL (for neonatal sepsis and pelvic inflammatory disease) and 30 ng/mL (for inflammatory bowel diseases) CRP in 1000-fold diluted blood respectively. In resource limited settings, the device can be used as a part of a kit (containing the device, a fixed-volume capillary, a pre-filled tube, a syringe, and a dropper); this kit would cost ~$0.50 when produced in large scale (>100,000 devices/week). This kit has the technical characteristics to be employed as a pre-screening tool, when combined with other data such as patient history and clinical signs.
Published Version: 10.1016/j.bios.2017.07.034
Terms of Use: This article is made available under the terms and conditions applicable to Open Access Policy Articles, as set forth at
Citable link to this page:
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search